2019
DOI: 10.1016/bs.vh.2019.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Estrogens as arbiters of sex-specific and reproductive cycle-dependent opioid analgesic mechanisms

Abstract: The organization of estrogenic signaling in the CNS is exceedingly complex. It is comprised of peripherally and centrally synthesized estrogens, and a plethora of types of estrogen receptor that can localize to both the nucleus and the plasma membrane. Moreover, CNS estrogen receptors can exist independent of aromatase (aka estrogen synthase) as well as oligomerize with it, along with a host of other membrane signaling proteins. This ability of CNS estrogen receptors to either to physically pair or exist separ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 111 publications
(123 reference statements)
1
0
0
Order By: Relevance
“…IL-6 can also promote osteoclastic activity and bone loss by activating the osteoprotegerin/receptor activator of nuclear factor kappa B ligand/ receptor activator of the nuclear factor kappa B (OPG/ RANKL/RANK) system, leading to osteoporosis [23]. In several animal models of chronic inflammation, estrogen can inhibit bone resorption and inflammation, reducing inflammation-mediated pain responses and the occurrence of neuroinflammatory diseases [24]. Our present findings are compatible with those of previous studies.…”
Section: Discussionsupporting
confidence: 91%
“…IL-6 can also promote osteoclastic activity and bone loss by activating the osteoprotegerin/receptor activator of nuclear factor kappa B ligand/ receptor activator of the nuclear factor kappa B (OPG/ RANKL/RANK) system, leading to osteoporosis [23]. In several animal models of chronic inflammation, estrogen can inhibit bone resorption and inflammation, reducing inflammation-mediated pain responses and the occurrence of neuroinflammatory diseases [24]. Our present findings are compatible with those of previous studies.…”
Section: Discussionsupporting
confidence: 91%
“…This may lessen pain responses that are triggered by inflammation and prevent the development of neuroinflammatory diseases. However, the exact mechanism is not fully understood [7].…”
Section: Effect Of Oestrogen On Postmenopausal Osteoporosismentioning
confidence: 99%